General Information of Drug (ID: DM25VY8)

Drug Name
Mydicar Drug Info
Synonyms Mydicar (TN)
Indication
Disease Entry ICD 11 Status REF
Heart failure BD10-BD13 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM25VY8

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gallopamil DMXBR27 Asthma CA23 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2) TTE6THL AT2A2_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT00534703) Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure and a Left Ventricular Assist Device. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Celladon.
3 Interaction of D-600 with the transmembrane domain of the sarcoplasmic reticulum Ca(2+)-ATPase. Am J Physiol Cell Physiol. 2000 Jul;279(1):C166-72.